US firms seeks dialogue to overcome SARS (severe acute respiratory syndrome) test hurdles
This article was originally published in Clinica
Executive Summary
Nine diagnostic companies met with US public health officials last week to discuss ways of resolving some of the potential logistical and regulatory impediments to the development of an accurate, inexpensive and rapid test for the SARS virus.